INTRODUCTION
Differentiation of the various hematopoietic lineages from pluripotent, self-renewing hematopoietic stem cells (HSC) is a tightly controlled process involving coordinate expression of lineage-specific genes. Transcriptional regulation of this process is necessary for normal hematopoiesis, as evidenced by the frequent involvement of transcription factor genes in leukemia-associated chromosomal translocations [1] . Nuclear receptors (NRs) are a family of transcription factors that bind cognate DNA sequences and activate transcription in a liganddependent manner [2] . The important role of NRs in hematopoiesis was highlighted by the discovery that chromosomal translocations involving the gene for the retinoic acid receptor-␣ (RAR␣) lead to acute promyelocytic leukemia (APL) in humans [3] . Furthermore, treatment of APL patients with RA, a ligand for RARs, leads to remission of disease in the majority of patients [4] . These findings paved the way for a significant body of research examining the roles of retinoids and their receptors in hematopoietic, particularly granulocytic, differentiation [5] .
Retinoid signaling is transduced by two families of NRs, the aforementioned RARs and the retinoid X receptors (RXRs), each family consisting of three members (␣, ␤, and ␥) [6 -9] . The RARs heterodimerize with RXRs to bind RA response elements, cis-acting DNA sequences found within the promoters of retinoid-responsive genes, and to modulate transcription by interactions with coactivators, corepressors, and other components of the transcriptional machinery [10, 11] . Like RARs, RXRs contain a central DNA binding domain (DBD) and amino-and carboxy-terminal activation domains termed, respectively, AF1 and AF2. The AF2 domain of the retinoid receptors includes the RA binding pocket. All-trans RA (ATRA) binds selectively to RARs, whereas 9-cis RA (9c-RA) binds RARs and RXRs [12, 13] .
Many studies addressing the roles of the retinoid receptors in hematopoietic differentiation have used cell lines that differentiate in response to RA treatment or have involved the overexpression of wild-type or mutant retinoid receptors [14 -20] . More recently, the creation of mice with targeted deletions of the RARs has allowed the study of retinoid signaling in primary hematopoietic cells and in vivo [21] [22] [23] [24] [25] . These studies have suggested that RARs are not necessary for granulopoiesis. However, when present, RARs modulate the rate of granulocytic differentiation according to the availability of ligand; liganded RARs accelerate differentiation, whereas unliganded RARs decelerate granulocyte differentiation [26] . Because of the clear associations of the RARs with granulopoiesis, most studies examining the role of retinoid signaling in hematopoiesis have focused on the RAR family of retinoid receptors. In this context, RXRs have generally been viewed as the obligate but passive heterodimeric partners to the RARs. However, in contrast to RARs, RXRs can modulate gene transcription as homodimers [27] . In addition, RXRs serve as the heterodimeric partners of the vitamin D receptor, the thyroid hormone receptor, the peroxisome proliferator-activated receptors, and other members of the NR family [28 -31] . Thus, RXRs would be expected to have overlapping functions with RARs but are poised to have an even more widespread influence on hematopoiesis than RARs. Despite this, relatively few studies of NR signaling in hematopoiesis have focused on RXRs [14, 15, 32] .
The three members of the RXR family show tissue-specific differences in expression [9] . Previous studies have suggested that the most abundant, or at least the most functionally important, RXR in myeloid cells is RXR␣ [14, [33] [34] [35] . To better understand the role of RXRs in various physiological processes, several groups have generated murine knockouts of RXRs [36] . RXR␥ null mice develop normally [37] . Roughly half of RXR␤ knockout mice die before or at birth; survivors appear normal, except that males are sterile [38] . Conventionally targeted RXR␣ knockout mice are embryonic-lethal [39, 40] .
To study the roles of RXR␣ in adult mice, we are using mice in which RXR␣ has been conditionally targeted for tissuespecific inactivation [41] . When crossed with Cre recombinase transgenic mice, RXR␣ is inactivated in those tissues in which Cre recombinase is expressed. We hypothesized that inactivating RXR␣ in early hematopoietic progenitors would compromise hematopoiesis and that we would find overlapping (with RARs) and nonoverlapping defects in hematopoiesis, reflecting the role of RXR␣ as a heterodimeric partner to several NR family members and its ability to modulate gene expression as a homodimer. For targeting the expression of Cre recombinase to the hematopoietic system, we obtained MxCre transgenic mice [42] . Early reports using MxCre to accomplish widespread and sustained inactivation of gene targets in hematopoietic cells had yielded inconsistent and sometimes conflicting results (unpublished data and private communications). Therefore, we also sought to systematically characterize MxCre mice for our use in studying the role of RXR␣ in hematopoietic cells.
MATERIALS AND METHODS

Mice
Conditionally targeted RXR␣ mice (RXR␣ fl/fl ) and MxCre transgenic mice, which have been described previously [41, 42] fl/fl littermate controls received a single induction regimen consisting of three i.p. injections of 300 g poly-inosine, poly-cytosine (pIpC; Sigma Chemical Co., St. Louis, MO), administered every other day. Mice used in these experiments were 3-5 months of age at the time of induction. Blood and tissues were harvested for analysis after an interval of 1 week-2 years after induction. Peripheral blood was drawn into EDTA-coated CapiJect T-MQK tubes (Terumo Medical Corp., Elkton, MD). Complete blood profiles were obtained using a Melet Schloesing MS9/-5 (El Cajon, CA). Prior to tissue harvest, animals were killed by carbon dioxide (CO 2 ) asphyxiation according to institutional guidelines. Bone marrow cells were collected from bilateral femurs and tibiae by flushing marrow cavities with PBS through a 25-gauge needle. Southern blot and DNA PCR analyses DNA was harvested using the Wizard genomic DNA purification kit (Promega, Madison, WI). Southern blot analysis was performed according to standard methodologies using BamHI and BglII for restriction digests [43] . The probe for Southern blot analysis and the PCR conditions for genotyping of tissues have been described previously [41] . To genotype flow-sorted cells, we designed a nested multiplex PCR strategy. To harvest genomic DNA from flow sorted cells, cell pellets consisting of 8 -10,000 cells were digested 2 h at 55°C in 30 l PBS containing 0.1 mg/ml Proteinase K (Invitrogen, Carlsbad, CA). Following a 15-min 95°C incubation, 1 l of each digest reaction was used in a 50-l first-round PCR reaction containing primers P3, P6, and P7, followed by a second round of PCR using primers P4, P5, and P8. Cycling conditions were 1 min at 95°C; 12 cycles consisting of 30 s at 94°C, 30 s at 66°C (0.5°C decrement per cycle), and 30 s at 72°C; 18 cycles consisting of 30 s at 94°C, 30 s at 62°C, and 30 s at 72°C; and 3 min at 72°C followed by a 4°C hold.
Magnetic cell sorting and FACS
Bone marrow cells were enriched for lineage-depleted cells using the StemSep™ murine progenitor enrichment cocktail and StemSep™ device (Stem Cell Technologies, Vancouver, BC, Canada), according to the manufacturer's instructions. Lineage-depleted cells were incubated with additional enrichment cocktail, washed in PBS/2% FBS, and incubated with PE-labeled strepavidin (PE-SAv) and FITC-labeled anti-stem cell antigen-1 (Sca-1; Ly-6A/E, BD Biosciences, San Jose, CA). Following a second wash, the cells were analyzed and sorted using a FACSVantage SE and CellQuest™ software (BD Biosciences). Freshly harvested bone marrow cells were analyzed by FACS. FITC-labeled (CD3, CD71, and GR-1) and PE-labeled (CD19, Ter119, and F4/80) antibodies were all obtained from PharMingen (San Diego, CA). A FACSCalibur flow cytometer and CellQuest™ software (BD Biosciences) were used for analysis. Propidium iodide was added to allow exclusion of dead cells from the analysis.
Cell culture
Bone marrow cells were cultured in preformulated methylcellulose medium (Methocult 3434, Stem Cell Technologies). Cells suspended in 3 mL methylcellulose medium were plated on 35 mm dishes and cultured at 37°C in a humidified, 5% CO 2 incubator, and colonies were counted starting at Day 5. When present, 9c-RA (Sigma Chemical Co.) was used at a final concentration of 1 M.
RT-PCR and qPCR
RNA was isolated from whole bone marrow using TRIzol (Invitrogen), DNase I-digested, and column-purified (RNeasy MinElute Cleanup; Qiagen, Valencia, CA). First-strand cDNA was synthesized using SuperScript II and random hexamers (Invitrogen) . To analyze splicing of the RXR␣ transcript, cDNA was PCR-amplified using Primers P9 and P10.
For quantitation of RXR␣, RXR␤, and RXR␥ expression, qPCR was performed using the ABI 7300 real-time PCR system (Applied Biosystems, Foster City, CA). Linearized, gel-purified, plasmid templates (pCMX-RXR␣, -RXR␤, and -RXR␥) were used as standards to quantitate RXR transcript levels. A column-purified (QIAquick PCR purification; Qiagen), 555-bp PCR amplicon served as a standard to quantitate cyclophilin transcript levels. Standards were quantitated by UV spectroscopy. For each standard template, quantitation was performed in triplicate at two different dilutions and on two separate UV spectrometers; the results were averaged. Template copy numbers were calculated based on molecular weights and concentrations of RXR and cyclophilin template controls. All amplification reactions were performed in a 20-l reaction volume consisting of 10 l 2ϫ SYBR GREEN PCR master mix (Applied Biosystems), 0.24 l each primer (300 nM final), and cDNA or control templates suspended in 9.52 l H 2 O. For bone marrow samples, the cDNA equivalent of 50 ng reverse-transcribed total RNA served as template for each qPCR reaction. For standards, a dilution series of 10 copies-1 billion copies of template per reaction was amplified to establish the linear amplification range for each primer set. Thermal cycling was initiated for 15 min at 95°C, followed by 50 cycles consisting of 10 s at 94°C, 20 s at 56°C, and 30 s at 72°C. Readings were taken during the 72°C step of each cycle. Amplification cycles were followed by melting curve analysis. Primers designed for each RXR isoform were challenged in mock amplification reactions to confirm that no amplification occurred from the other two isoform templates under the qPCR conditions used. Setups and amplifications of bone marrow samples and template controls were all performed in triplicate and were amplified simultaneously on a single 96-well plate to allow for valid, comparative quantitation. In every experiment, "No RT" controls and "No Template" controls were included.
Quantitation of RXR␣, RXR␤, and RXR␥ transcripts
qPCR results were analyzed using sequence detection system software (SDS 1.2, Applied Biosystems). Standard curves were generated by plotting cycle thresholds (C T ) against the logarithm of the starting template amount. All primers showed linear amplification over at least an 8-log range of template concentration. C T of bone marrow samples were determined for each amplified target, and the corresponding standard curves were used to convert C T values to transcript copy numbers. As the efficiency of RT is highly variable, quantitative comparisons were only made between qPCR results generated from a single RT reaction. RXR transcript levels were normalized to cyclophilin. For quantitation of RXR␣, RXR␤, and RXR␥ expression in RXR␣ fl/fl (wild-type) bone marrow and for comparison of RXR␤ and RXR␥ isoform levels in pIpC-treated MxCre ϩ /RXR fl/fl mice and RXR␣ fl/fl control mice, RNA was isolated from two mice of each type. Duplicate RT reactions were performed on each isolate, and each resulting cDNA mixture was used in qPCR.
Western blot analysis
Western blot analysis was done using standard procedures [43] . Total protein was extracted from bone marrow in SDS sample buffer, resolved by SDS-PAGE and transferred to polyvinylidene difluoride filters. 
RESULTS
MxCre mediates widespread and sustained loxP recombination in hematopoietic tissues and in bone marrow enriched for HSC To study the role of RXR␣ in hematopoiesis, we first assessed the extent of MxCre-mediated loxP recombination (floxout) in adult hematopoietic tissues. Relative levels of the RXR␣ flox and ⌬RXR␣ alleles in hematopoietic tissues were analyzed by PCR and by Southern blotting using the strategy shown in Figure 1A . PCR and Southern blot analyses demonstrated efficient deletion of the targeted RXR␣ flox allele and appearance of the ⌬RXR␣ null allele in MxCre ϩ /RXR␣ fl/fl mice ( Fig.  1 , B and C). Bone marrow showed the highest level of deletion (88.1%), spleen showed less-efficient gene deletion (67.5%), and thymus showed the least (44.1%). Among other tissues examined, the liver demonstrated the highest level of gene deletion (data not shown). Although the liver serves as a hematopoietic organ during fetal life, it is not a site of ongoing hematopoiesis in the normal adult mouse. Histologic examination confirmed the absence of ongoing hematopoiesis in the livers of MxCre ϩ /RXR␣ fl/fl and RXR␣ fl/fl mice (data not shown). As expected, pIpC treatment alone produced no effect on the floxed alleles in RXR␣ fl/fl control mice lacking the MxCre transgene.
Despite high levels of gene deletion in whole bone marrow, a small percentage (11.9%) of the original RXR␣ flox allele remained. This level of gene deletion in bone marrow is comparable with other published results [44, 45] . In adult mice, whole bone marrow consists primarily of granulocytic and erythroid precursors in various stages of terminal differentiation. Therefore, it is reasonable to conclude that MxCre-mediated gene deletion is efficient in these maturing cells. However, to study a lasting effect of gene deletion on hematopoietic differentiation or to assess effects on early stages of differentiation, it is important to establish that early progenitors also show efficient gene deletion. Percentage estimates of early bone marrow progenitors depend on the defining criteria used to identify these progenitors. When functional criteria are used to define HSC, estimates drop to 0.05% or fewer of all bone marrow cells ( Fig. 2A) [46, 47] (Fig. 2B) . DNA was genotyped using a nested, multiplex PCR strategy (Fig. 2C) . When analyzed on agarose gels, first-round PCR products from whole BM and post-column DNA isolates showed visible amplification of the 601-bp and 409-bp amplicons derived from the RXR␣ flox and ⌬RXR␣ alleles, respectively, whereas no amplification could be detected in DNA isolates from the sorted cell populations (data not shown). Aliquots of the first-round reactions were used in a second round of PCR. Products from both secondround reactions are shown in Figure 2D . The upper image depicts the results obtained when all three second-round primers were used, and the lower image demonstrates the findings obtained when primer P5 was excluded from the reaction mixture. When the second-round conditions allowed for simultaneous amplification of the RXR␣ flox and ⌬RXR␣ alleles ( tion conditions were changed to favor amplification of the RXR␣ flox allele, the presence of this 375-bp band was accentuated (Fig. 2D, lanes 2 and 3) . In contrast, the sorted cell populations, including the Lin -/Sca-1 ϩ subset enriched for HSC, showed complete absence of the RXR␣ flox allele. Therefore, in immunophenotypically defined hematopoietic progenitors highly enriched for HSC, only the ⌬RXR␣ null allele remains after pIpC induction of MxCre ϩ /RXR␣ fl/fl mice. HSC divide to produce the full repertoire of mature hematopoietic cells, but they are also, by definition, self-renewing. As a result of ongoing cell maturation and the continuous flushing out of maturing cells from the bone marrow to the peripheral circulation, the majority of hematopoietic cells present within the bone marrow at any given moment is soon replaced by the small subpopulation of progenitor (Ͻ5%) and stem (Ͻ0.05%) cells which are also present. The genotype of this small subpopulation of stem/progenitor cells will determine the eventual genotype of the bone marrow. To genotype this small subpopultion of cells, an enrichment strategy was necessary. CMP, Common myeloid progenitor; GMP, granulocyte/monocyte progenitor; MEP, megakaryocyte/erythrocyte progenitor; CLP, common lymphoid progenitor. (B) Strategy for enrichment of HSC. Triplicate pools of bone marrow from pIpC-induced MxCre ϩ /RXR␣ fl/fl mice were immunophenotypically labeled using a cocktail of biotinylated, mAb directed against lineage-specific antigens (CD5, CD45R, CD11b, GR-1, 7-4, and TER119) and subjected to immunomagnetic depletion of lineage-positive cells (Lin ϩ ). Whole bone marrow (Whole BM) and lineage-depleted (Post Column) whole bone marrow were serially incubated with fresh aliquots of biotinylated lineage antibody cocktail, with PE-SAv-labeled secondary antibody and with FITC-labeled anti-Sca-1. The cells were then analyzed by FACS. Lin ϩ /Sac-1 -, Lin ϩ /Sca-1 ϩ , and Lin -/Sca-1 ϩ cell populations were sorted for subsequent DNA isolation and PCR genotyping. Sort gates and the percentages of cells within these gates in whole bone marrow and in lineage-depleted bone marrow are indicated. (C) To facilitate detection of small numbers of flow-sorted bone marrow cells, a highly sensitive, nested multiplex PCR strategy using P3 in combination with the newly designed primers P4, P5, P6, P7, and P8 was performed. The first round of PCR used primers P3, P6, and P7. Following column purification, a volume equivalent to 1 l of the original 50-l first-round reaction volume was subjected to a second round of PCR using the primers P4, P5, and P8. Amplification products were analyzed by agarose gel electrophoresis. (D) For conditionally targeted MxCre ϩ /RXR␣ fl/fl mice, DNA isolated from whole bone marrow; lineage-depleted, presorted (Post Column) bone marrow; and three FACS cell populations was subjected to PCR. DNA isolated from the whole bone marrow of RXR␣ fl/fl control mice served as a control for the PCR. First-round PCR products (not shown) generated using primers P3, P6, and P7 were subjected to one of two alternative second rounds of PCR, one using the nested primers P4, P5, and P8 (products shown upper gel image) and one using primers P4 and P8 only (products shown lower gel image) to selectively amplify residual RXR␣ flox allele. First-and second-round PCR reactions were repeated several times, and the entire procedure of bone marrow harvest followed by cell sorting and PCR analysis was repeated twice.
Therefore, if MxCre induction results in RXR␣ gene deletion in HSC; then this deletion should endure over time, unless there is selection pressure against it. To confirm this prediction, we rechecked the mice for levels of gene deletion at several time-points after a single pIpC induction regimen. As shown in Figure 3 , bone marrow and spleen harvested from mice killed 1 month, 3 months, 1 year, and nearly 2 years after pIpC induction retain the ⌬RXR␣ null allele. These findings confirm the stability of bone marrow floxout over the normal murine lifespan and support the hypothesis that MxCre induction executes floxout to the level of the HSC. To look for RNA transcripts arising from the RXR␣ flox and ⌬RXR␣ alleles, we performed RT-PCR using primers situated in Exons 3 and 5 of RXR␣ (Fig. 4A) . As shown in Figure 4B , RT-PCR of RNA isolated from the whole bone marrows of MxCre (Fig. 4C) . It is of interest that we detected the appearance of a novel protein in bone marrow from MxCre ϩ /RXR␣ fl/fl mice that corresponds to the expected size for a shortened form (⌬Exon 4) of RXR␣. This short-form RXR␣ was not seen in other tissues or in peritoneal macrophages, wherein expression of RXR␣ is abundant (data not shown), suggesting that this short form RXR␣ may be unstable. Furthermore, deletion of RXR␣ Exon 4, which encodes the DBD, would prevent RXR␣ from binding DNA and activating transcription.
Expression of RXR␣, RXR␤, and RXR␥ in MxCre
Previous studies had suggested that RXR␣ is the predominant RXR in hematopoietic cells [14, [33] [34] [35] . To assess the relative expression of the three RXR isoforms in bone marrow and to determine if deletion of RXR␣ results in a compensational up-regulation of RXR␤ or RXR␥, we performed qPCR on total RNA and Western blot analysis on whole cell extracts of MxCre ϩ /RXR␣ fl/fl and RXR␣ fl/fl control bone marrows. Our qPCR data showed that RXR␣ and RXR␤ transcripts are comparably expressed in whole bone marrow of RXR␣ fl/fl control mice; RXR␣ showed only slightly higher expression than RXR␤ (Fig. 5A) . Western blot analysis demonstrated detectable levels of RXR␤ protein in bone marrows of MxCre ϩ / RXR␣ fl/fl mice and RXR␣ fl/fl controls (Fig. 5B , upper blot). There was no compensatory increase in expression of RXR␤ or RXR␥ following conditional targeting of RXR␣ (Fig. 5, A and B). Expression of RXR␥ was extremely low in bone marrow and virtually undetectable in most isolates by Western blot analysis and qPCR (Fig. 5, A and B) .
Hematopoietic consequences of RXR␣ floxout: in vivo analysis
Using the MxCre system, we proceeded to investigate the role of RXR␣ in hematopoiesis. We harvested peripheral blood from MxCre ϩ /RXR␣ fl/fl mice and littermate controls at multiple time-points after pIpC induction and performed complete blood profiles. Peripheral counts were within the normal range for both groups of mice ( Table 2) . No significant differences were observed between the red cell or white cell counts of MxCre ϩ /RXR␣ fl/fl mice and RXR␣ fl/fl controls. Peripheral blood differentials revealed comparable absolute lymphocyte, neutrophil, eosinophil, and monocyte counts. Bone marrows from MxCre ϩ /RXR␣ fl/fl mice and RXR␣ fl/fl controls demonstrated normal cellularity and a polymorphous mixture of maturing hematopoietic precursors, including the full spectrum of immature and mature neutrophilic precursors (Fig. 6A) , consistent with the normal counts seen in the peripheral blood. Bone marrow differential counts showed no significant difference between MxCre ϩ /RXR␣ fl/fl and RXR␣ fl/fl bone marrows ( Table 2 ). The spleens of both groups of mice showed maintenance of normal splenic architecture with small foci of residual, ongoing hematopoiesis concentrated in subcapsular regions (Fig. 6A) . FACS analysis performed using a panel of antibodies directed against lymphoid, erythroid, and myeloid antigens demonstrated comparable expression of B-and Tlymphoid (CD19 and CD3, respectively), erythroid (Ter119 vs. CD71), and myeloid (F4/80 vs. GR-1) antigens in MxCre ϩ / RXR␣ fl/fl and RXR␣ fl/fl control bone marrows (Fig. 6B) . No significant hematologic abnormalities were observed in either (Fig. 1A) were used in these PCR reactions. (*, PCR data from bone marrow harvested on Days 8 -9 is shown in Fig. 1C.) group of mice. These findings suggest that RXR␣ is dispensable for normal murine hematopoiesis.
Hematopoietic consequences of RXR␣ floxout: effects on in vitro colony formation
We performed colony assays on bone marrow cells isolated from MxCre ϩ /RXR␣ fl/fl mice and from RXR␣ fl/fl controls to assess for differences in colony formation. Bone marrow was cultured in methylcellulose culture medium supplemented with hematopoietic cytokines and 9c-RA or vehicle (ethanol). Colony counts were performed after 5 days of culture. Previous studies have shown that addition of RAR ligands (ATRA, 9c-RA) to methylcellulose culture medium suppresses colony formation by normal bone marrow cells [51, 52] . We consistently observed colony suppression by 9c-RA in bone marrow cultures of MxCre ϩ /RXR␣ fl/fl mice and RXR␣ fl/fl controls (Fig.  7) . In addition, bone marrow cells obtained from MxCre ϩ / RXR␣ fl/fl mice demonstrated a modest but consistent enhancement of colony formation as compared with bone marrow cells obtained from RXR␣ fl/fl controls (Fig. 7) . The most consistent 
DISCUSSION
Much of what is known about the roles played by various transcription factors in normal hematopoiesis has come from studies using conventional gene-targeting in mice. However, conventional gene-targeting of key hematopoietic regulators frequently leads to embryonic lethal phenotypes. In this context, embryonic lethality often reflects failure to progress from primitive to definitive hematopoiesis. Although fetal liver can provide a source of hematopoietic cells for in vitro studies of hematopoiesis, this system is less than ideal, as there are significant differences between fetal and adult hematopoiesis. Furthermore, conventional gene-targeting yields ample opportunity for developmental compensations that could obscure a gene's role under normal conditions. For these reasons, conditional gene-targeting is gaining favor as the targeting method of choice for studying a gene's role in adult-type hematopoiesis. There are currently several lines of Cre-expressing mice designed to target Cre recombinase expression to specific hematopoietic lineages within the hematopoietic compartment. However, the MxCre system is often used as the method of choice for targeting Cre recombinase expression to the whole hematopoietic system. As early reports using MxCre to accomplish widespread and sustained inactivation of gene targets in the hematopoietic system had yielded inconsistent results, we wished to establish the use of this system for studying the role of RXR␣ in hematopoiesis. Our findings confirm that MxCre mediates efficient recombination of floxed RXR␣ throughout the hematopoietic system. Furthermore, we demonstrate using a sensitive, nested PCR strategy that recombination is complete in bone marrow cells highly enriched for HSC. Consistent with these findings, we show that the recombined RXR␣ allele endures in bone marrow over the lifespan of the mice after a single induction. These findings validate the use of MxCre transgenic mice for conditional targeting of genes within the hematopoietic compartment and are consistent with the recent, important findings of others [45, 54] . Nonetheless, reports of failures to achieve a sustained floxout in hematopoietic cells when using MxCre are undoubtedly legitimate [55, 56] , highlighting at least three interesting points. First, failure to sustain floxout of a conditionally targeted gene within the hematopoietic compartment may be evidence that this gene serves a critical role during hematopoiesis [54 -56] . Repeat testing of bone marrow for maintenance of floxout is important when using MxCre to execute hematopoietic floxout of a conditionally targeted gene. Second, groups who experience failures using MxCre for long-term hematopoietic targeting presumably achieve similarly high levels of initial HSC floxout. Therefore, the regeneration of a bone marrow compartment in which the unrecombined allele again predominates suggests the presence of another, perhaps earlier, MxCre-unresponsive precursor cell outside the immunophenotypically defined (Lin -/Sca-1 ϩ ) HSC subset. It could be suggested that MxCre-unresponsive precursors are present within the Sca-1 -/Lin -subset of bone marrow cells, the sole unsorted cell population in Figure 2C 6 /l 9.1 Ϯ 0. -subset of bone marrow cells [57, 58] . Alternatively, it is possible that MxCre-unresponsive precursors are not well-sampled by bone marrow harvest, perhaps as a result of tight adherence to bone marrow stroma. Finally, the fact that we and others see maintenance of MxCre-mediated floxout in bone marrow suggests that MxCre-unresponsive precursors outside the immunophenotypically defined Lin -/Sca1 ϩ subset do not normally contribute significantly to the bone marrow cell pool over the murine lifespan; perhaps a significant hematopoietic challenge is required to stimulate these otherwise quiescent precursors.
As the MxCre transgene yielded widespread and stable inactivation of RXR␣, we were able to study the long-term hematopoietic consequences of inactivating RXR␣. We predicted that conditionally targeted RXR␣ mice would show defects in hematopoiesis and that we would find overlapping (with RARs) and nonoverlapping defects in hematopoiesis, reflecting the role of RXR␣ as a heterodimeric partner to several NR family members and its ability to modulate gene expression as a homodimer. However, we find that in the absence of RXR␣, murine hematopoiesis proceeds normally.
We see no evidence of hematologic compromise in mice lacking RXR␣. It is surprising that we are able to detect a ⌬RXR␣ protein product in bone marrow from MxCre ϩ /RXR␣ fl/fl mice (Fig. 4C) . But given the presence of detectable short form (presumed ⌬Exon 4) RXR␣ protein in bone marrow, the absence of a hematopoietic phenotype in pIpC-treated MxCre ϩ / RXR␣ fl/fl mice raises the question of whether targeting of RXR␣ by deleting its DBD results in a true null phenotype. As RXR␣ cannot function to activate gene transcription in the absence of its DBD, RXR␣ is truly null for this activity following deletion of Exon 4. Furthermore, when crossed with protamine-Cre transgenic mice, this line of conditionally targeted RXR␣ fl/fl mice recapitulates the embryonic lethal phenotype observed in conventionally targeted RXR␣ Ϫ/Ϫ mice [41] . This argues that conditional targeting of RXR␣ through removal of its DBD is equivalent to conventional targeting for the production of a null phenotype. A concern raised by the presence of a short-form (DBD-deleted) RXR␣ would be that this aberrant protein could interact with normal NRs and interfere with their normal functions. Thus, dominant-negative activity by a short-form RXR␣ could be expected to yield false-positive phenotypes not attributable to absence of RXR␣. Bone marrow smears were stained using Wright-Giemsa. Formalin-fixed, paraffin-embedded bone marrow and spleen sections were stained with H&E. Original magnifications, ϫ400 (i, ii, iv, v) and ϫ100 (iii, vi The absence of a phenotype in these mice argues that no dominant-negative activity is occurring, perhaps due to instability of this aberrant protein as our data suggest. Although it remains possible that hematopoietic challenge might reveal hematopoietic defects in MxCre ϩ /RXR␣ fl/fl mice, our findings suggest that RXR␣ is dispensable for normal murine hematopoiesis.
Although previous studies looking at the role of RXRs in hematopoietic growth and differentiation have focused primarily on RXR␣, we find that in bone marrow, RXR␤ is expressed at a level comparable with RXR␣. Furthermore, when RXR␣ is conditionally inactivated by expression of Cre recombinase, there is no compensatory up-regulation of RXR␤. Previous studies have found that RXR␥ is scarce in hematopoietic cells. Similarly, we find that RXR␥ is virtually undetectable in bone marrow. Taken together, these findings suggest that RXR␤, at baseline levels of expression, compensates for the loss of RXR␣ in MxCre ϩ /RXR␣ fl/fl bone marrow cells and fulfills the normal (steady-state), hematopoietic requirement for RXR. This result is somewhat surprising, as RXR␤ has not been implicated to serve an important role in hematopoiesis. Nonetheless, a recent study found that RXR␤ expression exceeds that of RXR␣ in human CD34
ϩ hematopoietic progenitor cells [59] . This finding is consistent with our results in the mouse system and could further explain the absence of a significant hematopoietic deficit in MxCre ϩ /RXR␣ fl/fl mice. It is possible that RXR␤ is the functionally dominant RXR in early myeloid precursors and that the emphasis on RXR␣ reflects a bias toward studying macrophages and other mature myeloid cell types, wherein RXR␣ expression significantly exceeds that of RXR␤. In colony assays, we see that colony formation by RXR␣ null bone marrow cells is suppressed by 9c-RA. This result is well-described and has been attributed to RAR/RXR heterodimer function [51, 60] . The fact that we continue to see this effect in RXR␣ null bone marrow further supports the idea that RXR␤ satisfies the requirement of RAR for a heterodimeric partner in hematopoietic cells. It is interesting that we also observed that in the absence of ligand, RXR␣ null bone marrow cells formed colonies more efficiently than bone marrow cells obtained from control mice. Although the biological significance of this finding is unclear, it could suggest that, although RXR␣ is not required for murine hematopoiesis, there may be hematopoietic signaling pathways that respond selectively to RXR␣ or settings in which baseline expression of RXR␤ is limiting when there is competition for RXR. These questions regarding the functional redundancy of RXR␣ and RXR␤ in hematopoietic cells could be better-addressed using mice in which both RXR␣ and RXR␤ are simultaneously targeted within the hematopoietic system. This remains an area for future study. 
